Sensitivity and specificity of metaiodobenzylguanidine (MIBG) myocardial accumulation in the diagnosis of Lewy body diseases in a movement disorder clinic

Parkinsonism and Related Disorders

Volumn 17, Issue 5, 2011, Pages 395-397

  Tateno, Fuyuki ^a   Sakakibara, Ryuji ^a   Kishi, Masahiko ^a   Ogawa, Emina ^a   Terada, Hitoshi ^a   Ogata, Tsuyoshi ^a   Haruta, Hiroyuki ^a  

^a TOHO UNIVERSITY   (Japan)

Author keywords

Dementia with Lewy bodies; Metaiodobenzylguanidine (MIBG); Parkinson's disease; Pure autonomic failure

Indexed keywords

(3 IODOBENZYL)GUANIDINE;

ADULT; AGED; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIFFUSE LEWY BODY DISEASE; FEMALE; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; MYOCARDIAL PERFUSION IMAGING; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

3-IODOBENZYLGUANIDINE; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; LEWY BODY DISEASE; MALE; MIDDLE AGED; MYOCARDIUM; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 79957945002     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2011.02.001     Document Type: Letter

References (5)

1. Orimo S., Uchihara T., Nakamura A., Mori F., Kakita A., Wakabayashi K., et al. Axonal alpha-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson's disease. Brain 2008, 131:642-650.
2. Braune S. The role of cardiac metaiodobenzylguanidine uptake in the differential diagnosis of parkinsonian syndromes. Clin Auton Res 2001, 11:351-355.
3. Nagayama H., Hamamoto M., Ueda M., Nagashima J., Katayama Y. Reliability of MIBG myocardial scintigraphy in the diagnosis of Parkinson's disease. J Neurol Neurosurg Psychiatry 2005, 76:249-251.
4. Yoshita M., Taki J., Yokoyama K., Noguchi-Shinohara M., Matsumoto Y., Nakajima K., et al. Value of 123I-MIBG radioactivity in the differential diagnosis of DLB from AD. Neurology 2006, 66:1850-1854.
5. Ishibashi K., Saito Y., Murayama S., Kanemaru K., Oda K., Ishiwata K., et al. Validation of cardiac (123)I-MIBG scintigraphy in patients with Parkinson's disease who were diagnosed with dopamine PET. Eur J Nucl Med Mol Imaging 2010, 37:3-11.